haloperidol has been researched along with cytosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirokane, G; Morita, S; Okawa, M; Shimoda, K; Someya, T; Takahashi, S; Yokono, A | 1 |
| Banerjee, M; Nair, C; Nair, IV; Saradalekshmi, KR; Swathy, B | 1 |
2 other study(ies) available for haloperidol and cytosine
| Article | Year |
|---|---|
Lack of impact of CYP1A2 genetic polymorphism (C/A polymorphism at position 734 in intron 1 and G/A polymorphism at position -2964 in the 5'-flanking region of CYP1A2) on the plasma concentration of haloperidol in smoking male Japanese with schizophrenia.
Topics: 5' Flanking Region; Adenine; Adult; Aged; Antipsychotic Agents; Cytochrome P-450 CYP1A2; Cytosine; Enzyme Induction; Guanine; Haloperidol; Humans; Introns; Japan; Male; Middle Aged; Point Mutation; Polymorphism, Genetic; Schizophrenia; Smoking | 2002 |
Understanding the influence of antipsychotic drugs on global methylation events and its relevance in treatment response.
Topics: 5-Methylcytosine; Adult; Antipsychotic Agents; Case-Control Studies; Clozapine; Cytosine; DNA; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Epigenesis, Genetic; Female; Haloperidol; Hep G2 Cells; Humans; Male; MicroRNAs; Olanzapine; Pharmacogenetics; Schizophrenia; Treatment Outcome | 2018 |